Literature DB >> 19760131

Both dorsal and ventral flaps can be used in previously circumcised hypospadic adults with comparable success rates.

Berk Burgu1, Ozgu Aydogdu, Haluk Söylemez, Tarkan Soygur.   

Abstract

OBJECTIVE: To compare dorsal and ventral dartos flap outcomes for tubularized incised-plate urethroplasty (TIPU) in terms of success, complication rates and cosmetic appearance in adult circumcised hypospadic men.
METHODS: Forty-two circumcised adult men underwent primary distal or midpenile hypospadias repair for cosmetic reasons by a single surgeon in a prospective randomized trial. Twenty-two patients were randomly selected for TIPU repair with dorsal (Group1, mean age 22.3 years) dartos flap as second layer. Twenty patients were randomly selected for TIPU repair with ventral dartos flap (Group2, mean age 21.1 years). Satisfaction questionnaires were answered by patients before surgery and at postoperative 6 weeks. The operating surgeon also filled in the form blindly at the same postoperative period. The differences between pre and postoperative satisfaction scores for each group were also evaluated. Preoperatively, all cases were evaluated with uroflowmetry and compared with postoperative results measured at 6th week of surgery. P < 0.05 was considered as significant.
RESULTS: Mean follow-up was 24 months (4-28). Complications were encountered in 18 and 20% of the patients in groups 1 and 2, respectively. Complications were urethrocutaneous fistula, meatal stenosis, retrusive/proximal meatus and residual curvature. Success rates were 82 and 80%, respectively. No differences were seen in overall satisfaction between the two groups (P = 0.07).
CONCLUSION: Outcome of hypospadias repair in circumcised adults for cosmetic reasons is similar to uncircumcised hypospadics previously mentioned in the literature. Both dorsal and ventral flaps can be used in previously circumcised hypospadic adults with comparable satisfaction and complication rates and uroflow findings.

Entities:  

Mesh:

Year:  2009        PMID: 19760131     DOI: 10.1007/s11255-009-9638-6

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  24 in total

1.  Prior circumcision does not complicate repair of hypospadias with an intact prepuce.

Authors:  Warren T Snodgrass; Rose Khavari
Journal:  J Urol       Date:  2006-07       Impact factor: 7.450

2.  Hypospadias trends in two US surveillance systems.

Authors:  L J Paulozzi; J D Erickson; R J Jackson
Journal:  Pediatrics       Date:  1997-11       Impact factor: 7.124

3.  Failed hypospadias repair presenting in adults.

Authors:  Guido Barbagli; Michele De Angelis; Enzo Palminteri; Massimo Lazzeri
Journal:  Eur Urol       Date:  2006-02-03       Impact factor: 20.096

Review 4.  Comparison of outcomes of tubularized incised plate hypospadias repair and circumcision: a questionnaire-based survey of parents and surgeon.

Authors:  Warren Snodgrass; Ali Ziada; Selcuk Yucel; Amit Gupta
Journal:  J Pediatr Urol       Date:  2008-03-07       Impact factor: 1.830

5.  Rise in prevalence of hypospadias.

Authors:  H Dolk
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

6.  Hypospadias in adults.

Authors:  Temuçin Senkul; Kenan Karademir; C neyt Işeri; D oan Erden; Kadir Baykal; C neyt Adayener
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

7.  Tubularized, incised plate urethroplasty for distal hypospadias.

Authors:  W Snodgrass
Journal:  J Urol       Date:  1994-02       Impact factor: 7.450

8.  Re-operative hypospadias repair using the Snodgrass incised plate urethroplasty.

Authors:  A M Shanberg; K Sanderson; B Duel
Journal:  BJU Int       Date:  2001-04       Impact factor: 5.588

9.  Distal hypospadias repair in adults: the results of 97 cases.

Authors:  Cuneyt Adayener; Ilker Akyol
Journal:  Urol Int       Date:  2006       Impact factor: 2.089

10.  Primary and reoperative hypospadias repair with the Snodgrass technique.

Authors:  A B Retik; J G Borer
Journal:  World J Urol       Date:  1998       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.